[1]
U. Maestroni, D. M. Cavalieri, D. Campobasso, G. Guarino, and F. Ziglioli, “PSA-IgM and iXip in the diagnosis and management of prostate cancer: clinical relevance and future potential. A review”., Acta Biomed, vol. 92, no. 6, p. e2021344, Jan. 2022, doi: 10.23750/abm.v92i6.12058.